Indeed, in amyotrophic lateral sclerosis transgenic mice systemic administration of VEGF resulted in an increase in the number of NMJs in the diseased mice (Zheng et al., 2007). This evidence concerns the gene VEGFA and amyotrophic lateral sclerosis.